Halberd

Halberd ROCE

The Return on Capital Employed (ROCE) of Halberd (HALB) as of Oct 10, 2026 is 2.04 %. In the previous year, Return on Capital Employed (ROCE) was 10.44 % — a change of -80.43% (lower).

ROCE

2.04 %

YoY

-80.43%

Last updated:

In 2025, Halberd's return on capital employed (ROCE) was 2.04 %, a -80.43% increase from the 10.44 % ROCE in the previous year.

The Halberd ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2016
-11.88 USD
Jan 1, 2017
38.24 USD
Jan 1, 2020
576.88 USD
Jan 1, 2021
176.30 USD
Jan 1, 2022
222.37 USD
Jan 1, 2023
48.27 USD
Jan 1, 2024
10.44 USD
Jan 1, 2025
2.04 USD
The Halberd ROCE history
YEARROCEYoY
2.04 %-80.43%
10.44 %-78.36%
48.27 %-78.29%
222.37 %+26.13%
176.30 %-69.44%
576.88 %+1,408.75%
38.24 %-421.79%
-11.88 %—
Access this data via the Eulerpool API

Halberd Stock analysis

What does Halberd do? The Halberd Corp is an American company founded in 1987 and based in New York. It is a high-tech company focused on the development of medical technologies. Since its inception, the company has developed numerous innovative products and technologies that are used worldwide. A significant portion of Halberd Corp's business model focuses on providing medical products and solutions for various diseases. The main divisions of the company are biotechnology and pharmaceuticals, medical respiratory protection, medical technology, and the development of antibodies and diagnostics. Some of the most well-known products of Halberd Corp are the Medical Respiratory Masks, which were of great importance during the COVID-19 pandemic. These masks were developed and distributed worldwide by the company with innovative technology and the highest quality standards. The company has also developed various medical devices such as infusion pumps, blood pressure monitors, and various diagnostic devices that have been used by hospitals and care facilities. Another important business area of Halberd Corp is biotechnology and pharmaceuticals. In this field, the company specializes in developing new drugs and therapies for various diseases. The company has developed a range of proprietary medications that are used in the treatment of various diseases. Halberd Corp is also known for its development of antibodies and diagnostics and offers corresponding test kits. In recent years, Halberd Corp has formed numerous partnerships with other companies and institutions to bring its innovations to the market and market them. The company is also known for its successful joint ventures with other companies in the healthcare sector. Overall, Halberd Corp is an innovative company focused on medical technologies. With its presence in various areas of the healthcare industry, the company is able to develop new products and solutions that have the potential to improve and save lives. Halberd is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Halberd's Return on Capital Employed (ROCE)

Halberd's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Halberd's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Halberd's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Halberd’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Halberd stock

Return on Capital Employed (ROCE) of Halberd is 2.04 % in 2025.

Return on Capital Employed (ROCE) of Halberd changed from 10.44 % to 2.04 %, representing a -80.43% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Halberd since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Halberd with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

Profitability — Halberd

All Key Metrics — Halberd